Literature DB >> 24260613

Unilateral hydronephrosis caused by invasive mole: a case report.

Hai-Yan Zhang1, Wei Wu, Jin Zhu.   

Abstract

Invasive mole belongs to gestational trophoblastic neoplasm, which is a highly curable group of pregnancy-related tumors. However, approximately 20% of gestational trophoblastic tumors will be resistant to or relapsed after initial chemotherapy. These resistant and relapsed lesions will require salvage chemotherapy with or without surgery. It is still unclear which regimens are the most effective and least toxic. Here, we report a case of unilateral hydronephrosis presenting 1 week after a history of curettage because of a hydatidiform mole. With the combination treatments of chemotherapy and surgery, the patient was cured.

Entities:  

Keywords:  Gestational trophoblastic neoplasm; chemotherapy; hydronephrosis; surgery

Year:  2013        PMID: 24260613      PMCID: PMC3832344     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  15 in total

1.  A rare cause of hydronephrosis: invasive mole.

Authors:  Bulent Ozdal; Tayfun Güngör; Cigdem Demirel; Ulkü Mete; M A Serkan Ozkul
Journal:  Ann Saudi Med       Date:  2006 Jul-Aug       Impact factor: 1.526

2.  Role of adjuvant hysterectomy in management of high-risk gestational trophoblastic neoplasia.

Authors:  Jing Fang; Shu Wang; Xiaobing Han; Ruifang An; Weimin Wang; Yan Xue
Journal:  Int J Gynecol Cancer       Date:  2012-03       Impact factor: 3.437

3.  [Analysis of prophylactic chemotherapy outcome and clinical characteristics in patients of high-risk hydatidiform mole].

Authors:  Shuo Geng; Feng-zhi Feng; Yang Xiang; Xi-run Wan; Ying Zhou
Journal:  Zhonghua Fu Chan Ke Za Zhi       Date:  2011-01

4.  Transvaginal ultrasound predicts delayed response to chemotherapy and drug resistance in stage I low-risk trophoblastic neoplasia.

Authors:  P Cavoretto; C Gentile; G Mangili; E Garavaglia; L Valsecchi; D Spagnolo; S Montoli; M Candiani
Journal:  Ultrasound Obstet Gynecol       Date:  2012-07       Impact factor: 7.299

Review 5.  Genetics of gestational trophoblastic neoplasia: an update for the clinician.

Authors:  Constantine Alifrangis; Michael J Seckl
Journal:  Future Oncol       Date:  2010-12       Impact factor: 3.404

Review 6.  Gestational trophoblastic neoplasia management: an update.

Authors:  Sarah Ngan; Michael J Seckl
Journal:  Curr Opin Oncol       Date:  2007-09       Impact factor: 3.645

7.  Comparing cisplatin-based combination chemotherapy with EMA/CO chemotherapy for the treatment of high risk gestational trophoblastic neoplasia.

Authors:  C Lybol; C M G Thomas; E A Blanken; F C G J Sweep; R H Verheijen; A M Westermann; I A Boere; A K L Reyners; L F A G Massuger; R Q G C M van Hoesel; P B Ottevanger
Journal:  Eur J Cancer       Date:  2012-10-23       Impact factor: 9.162

8.  Gestational trophoblastic disease: a 21-year review of the clinical experience at an Argentinean public hospital.

Authors:  Maria Inés Bianconi; Silvina Otero; Oriana Moscheni; Lucia Alvarez; Claudio Storino; Gustavo Jankilevich
Journal:  J Reprod Med       Date:  2012 Jul-Aug       Impact factor: 0.142

9.  Clinical parameters predicting therapeutic response to surgical management in patients with chemotherapy-resistant gestational trophoblastic neoplasia.

Authors:  Fengzhi Feng; Yang Xiang; Lei Li; Xirun Wan; Xiuyu Yang
Journal:  Gynecol Oncol       Date:  2009-04-05       Impact factor: 5.482

Review 10.  The management of recurrent and drug-resistant gestational trophoblastic neoplasia (GTN).

Authors:  E S Newlands
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2003-12       Impact factor: 5.237

View more
  1 in total

1.  Unusual Presentation of Invasive Mole: A Case Report.

Authors:  Soheila Aminimoghaddam; Andisheh Maghsoudnia
Journal:  J Reprod Infertil       Date:  2017 Jan-Mar
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.